Recap: Kala Pharmaceuticals Q2 Earnings



Kala Pharmaceuticals KALA reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Kala Pharmaceuticals beat estimated earnings by 18.6%, reporting an EPS of $-0.35 versus an estimate of $-0.43.

Revenue was down $951 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 0.16% drop in the share price the next day.

Here's a look at Kala Pharmaceuticals's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.36 -0.41 -0.43 -0.45
EPS Actual -0.40 -0.68 -0.43 -0.57
Revenue Estimate 3.07M 3.41M 5.16M 5.33M
Revenue Actual 1.37M 1.86M 3.07M 3.05M

To track all earnings releases for Kala Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!